(By Alia Paavola for Becker’s Hospital Review)
Seven pharma executives will testify Feb. 26 before a U.S. Senate Finance Committee investigating the reasons for escalating prescription drug costs.
Before the finger-pointing begins, the Federation of American Hospitals released a fact sheet on drug cost findings presented in a recent study it released with the American Hospital Association and the American Society of Health System Pharmacies: Continue reading article here…
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.